Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Short

Showing results (91-100 of 659) with videos related to

Pageof 66
Sort By:
Expert Review of Hematology|May 10, 2024
Is next-generation sequencing the future of measurable residual disease assays for Philadelphia chromosome-positive acute lymphoblastic leukemia?Nicholas J Short, Hagop Kantarjian, Elias Jabbour
Nature Communications|June 28, 2014
Work extraction and thermodynamics for individual quantum systemsPaul Skrzypczyk, Anthony J Short, Sandu Popescu
Leukemia & Lymphoma|June 8, 2024
Advances in the treatment of adults with newly diagnosed B-cell acute lymphoblastic leukemia: the role of frontline immunotherapy-based regimensNicholas J Short, Hagop Kantarjian, Elias Jabbour
Family Medicine|February 24, 2001
Family medicine scholars: a longitudinal enrichment program for medical studentsJ Short, P M Diller, R Ricer
Current Opinion in Neurology|March 7, 1998
Current concepts: spinal injuries and rehabilitationW S el Masry, D J Short
Leukemia|June 26, 2021
Optimizing the treatment of acute lymphoblastic leukemia in younger and older adults: new drugs and evolving paradigmsNicholas J Short, Hagop Kantarjian, Elias Jabbour
Physical Review. E|September 16, 2021
Eigenstate thermalization on averageJoe Dunlop, Oliver Cohen, Anthony J Short
Current Hematologic Malignancy Reports|August 31, 2023
An Update on the Management of Advanced Phase Chronic Myeloid LeukemiaNicholas J Short, Jayastu Senapati, Elias Jabbour
Blood Cancer Journal|September 11, 2023
Treatment of older adults with FLT3-mutated AML: Emerging paradigms and the role of frontline FLT3 inhibitorsNicholas J Short, Daniel Nguyen, Farhad Ravandi
Journal of Child Language|June 1, 1997
Preschoolers' communication during scripted interactionsK J Short-Meyerson, L J Abbeduto
Pageof 66

Showing results (91-100 of 659) with videos related to

Sort By:
Pageof 66
Expert Review of Hematology|May 10, 2024
Is next-generation sequencing the future of measurable residual disease assays for Philadelphia chromosome-positive acute lymphoblastic leukemia?Nicholas J Short, Hagop Kantarjian, Elias Jabbour
Nature Communications|June 28, 2014
Work extraction and thermodynamics for individual quantum systemsPaul Skrzypczyk, Anthony J Short, Sandu Popescu
Leukemia & Lymphoma|June 8, 2024
Advances in the treatment of adults with newly diagnosed B-cell acute lymphoblastic leukemia: the role of frontline immunotherapy-based regimensNicholas J Short, Hagop Kantarjian, Elias Jabbour
Family Medicine|February 24, 2001
Family medicine scholars: a longitudinal enrichment program for medical studentsJ Short, P M Diller, R Ricer
Current Opinion in Neurology|March 7, 1998
Current concepts: spinal injuries and rehabilitationW S el Masry, D J Short
Leukemia|June 26, 2021
Optimizing the treatment of acute lymphoblastic leukemia in younger and older adults: new drugs and evolving paradigmsNicholas J Short, Hagop Kantarjian, Elias Jabbour
Physical Review. E|September 16, 2021
Eigenstate thermalization on averageJoe Dunlop, Oliver Cohen, Anthony J Short
Current Hematologic Malignancy Reports|August 31, 2023
An Update on the Management of Advanced Phase Chronic Myeloid LeukemiaNicholas J Short, Jayastu Senapati, Elias Jabbour
Blood Cancer Journal|September 11, 2023
Treatment of older adults with FLT3-mutated AML: Emerging paradigms and the role of frontline FLT3 inhibitorsNicholas J Short, Daniel Nguyen, Farhad Ravandi
Journal of Child Language|June 1, 1997
Preschoolers' communication during scripted interactionsK J Short-Meyerson, L J Abbeduto
Pageof 66